Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.007 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Effects of dalcetrapib in patients with a recent acute coronary syndromeSchwartz, G.; Olsson, A.; Ballantyne, C.; Abt, M.; Barter, P.; Brumm, J.; Chaitman, B.; Holme, I.; Kallend, D.; Leiter, L.; Leitersdorf, E.; McMurray, J.; Mundl, H.; Nicholls, S.; Shah, P.; Tardif, J.; Wright, R.
2013Factors underlying regression of coronary atheroma with potent statin therapyPuri, R.; Nissen, S.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; St. John, J.; Wolski, K.; Uno, K.; Kataoka, Y.; Nicholls, S.
2013Coronary atheroma volume and cardiovascular events during maximally intensive statin therapyPuri, R.; Nissen, S.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
2014Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from study of coronary atheroma by intravascular ultrasound: effect of rosuvastatin versus atorvastatinPuri, R.; Nissen, S.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
2014Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURNPuri, R.; Nissen, S.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
2013C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapyPuri, R.; Nissen, S.; Libby, P.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
2017Aldosterone does not predict cardiovascular events following acute coronary syndrome in patients initially without heart failurePitts, R.; Gunzburger, E.; Ballantyne, C.; Barter, P.; Kallend, D.; Leiter, L.; Leitersdorf, E.; Nicholls, S.; Shah, P.; Tardif, J.; Olsson, A.; McMurray, J.; Kittelson, J.; Schwartz, G.
2018Association of lipoprotein(a) with risk of recurrent ischemic events following acute coronary syndrome: analysis of the dal-outcomes randomized clinical trialSchwartz, G.; Ballantyne, C.; Barter, P.; Kallend, D.; Leiter, L.; Leitersdorf, E.; McMurray, J.; Nicholls, S.; Olsson, A.; Shah, P.; Tardif, J.-.C.; Kittelson, J.
2014High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: Insights from SATURNStegman, B.; Puri, R.; Cho, L.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nissen, S.; Nicholls, S.